bioMérieux S.A. (OTCMKTS:BMXMF – Get Free Report)’s stock price passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $121.92 and traded as high as $125.44. bioMérieux shares last traded at $125.44, with a volume of 1 shares trading hands.
bioMérieux Trading Down 0.4 %
The stock’s fifty day moving average price is $121.92 and its 200-day moving average price is $114.01. The company has a current ratio of 2.21, a quick ratio of 1.20 and a debt-to-equity ratio of 0.10.
About bioMérieux
bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.
Featured Stories
- Five stocks we like better than bioMérieux
- What is a buyback in stocks? A comprehensive guide for investors
- Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential?
- Overbought Stocks Explained: Should You Trade Them?
- Disney 2025 Shareholders: Major Updates for Investors
- What Do S&P 500 Stocks Tell Investors About the Market?
- Advance Auto Parts Stock: A Classic Rebound Play in the Making
Receive News & Ratings for bioMérieux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioMérieux and related companies with MarketBeat.com's FREE daily email newsletter.
